nodes	percent_of_prediction	percent_of_DWPC	metapath
Pasireotide—Arthralgia—Topotecan—lung cancer	0.00165	0.00297	CcSEcCtD
Pasireotide—Myalgia—Topotecan—lung cancer	0.00165	0.00297	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Paclitaxel—lung cancer	0.00163	0.00294	CcSEcCtD
Pasireotide—Arthralgia—Erlotinib—lung cancer	0.00163	0.00293	CcSEcCtD
Pasireotide—Myalgia—Erlotinib—lung cancer	0.00163	0.00293	CcSEcCtD
Pasireotide—Anxiety—Erlotinib—lung cancer	0.00163	0.00292	CcSEcCtD
Pasireotide—Abdominal distension—Paclitaxel—lung cancer	0.00161	0.0029	CcSEcCtD
Pasireotide—Back pain—Vinorelbine—lung cancer	0.0016	0.00288	CcSEcCtD
Pasireotide—Influenza—Paclitaxel—lung cancer	0.0016	0.00288	CcSEcCtD
Pasireotide—Pain in extremity—Docetaxel—lung cancer	0.00157	0.00282	CcSEcCtD
Pasireotide—Nausea—Pemetrexed—lung cancer	0.00156	0.00281	CcSEcCtD
Pasireotide—Nausea—Gefitinib—lung cancer	0.00155	0.00279	CcSEcCtD
Pasireotide—Anaemia—Vinorelbine—lung cancer	0.00153	0.00275	CcSEcCtD
Pasireotide—Asthenia—Teniposide—lung cancer	0.00153	0.00275	CcSEcCtD
Pasireotide—Pruritus—Teniposide—lung cancer	0.00151	0.00271	CcSEcCtD
Pasireotide—Oedema peripheral—Gemcitabine—lung cancer	0.00151	0.00271	CcSEcCtD
Pasireotide—Vertigo—Vinorelbine—lung cancer	0.00149	0.00268	CcSEcCtD
Pasireotide—Diarrhoea—Teniposide—lung cancer	0.00146	0.00262	CcSEcCtD
Pasireotide—Hyperglycaemia—Paclitaxel—lung cancer	0.00144	0.00259	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Topotecan—lung cancer	0.00144	0.00259	CcSEcCtD
Pasireotide—Dry skin—Docetaxel—lung cancer	0.00144	0.00259	CcSEcCtD
Pasireotide—Abdominal pain upper—Docetaxel—lung cancer	0.00143	0.00258	CcSEcCtD
Pasireotide—Hypertension—Vinorelbine—lung cancer	0.00143	0.00257	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Erlotinib—lung cancer	0.00142	0.00256	CcSEcCtD
Pasireotide—Insomnia—Erlotinib—lung cancer	0.00141	0.00254	CcSEcCtD
Pasireotide—Decreased appetite—Vinblastine—lung cancer	0.00141	0.00254	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Docetaxel—lung cancer	0.00141	0.00254	CcSEcCtD
Pasireotide—Myalgia—Vinorelbine—lung cancer	0.00141	0.00254	CcSEcCtD
Pasireotide—Arthralgia—Vinorelbine—lung cancer	0.00141	0.00254	CcSEcCtD
Pasireotide—Nasopharyngitis—Docetaxel—lung cancer	0.0014	0.00252	CcSEcCtD
Pasireotide—Constipation—Vinblastine—lung cancer	0.00139	0.0025	CcSEcCtD
Pasireotide—Alopecia—Irinotecan—lung cancer	0.00139	0.00249	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Docetaxel—lung cancer	0.00138	0.00249	CcSEcCtD
Pasireotide—Decreased appetite—Topotecan—lung cancer	0.00137	0.00247	CcSEcCtD
Pasireotide—Fatigue—Topotecan—lung cancer	0.00136	0.00245	CcSEcCtD
Pasireotide—Decreased appetite—Erlotinib—lung cancer	0.00136	0.00244	CcSEcCtD
Pasireotide—Vomiting—Teniposide—lung cancer	0.00136	0.00244	CcSEcCtD
Pasireotide—Constipation—Topotecan—lung cancer	0.00135	0.00243	CcSEcCtD
Pasireotide—Alopecia—Gemcitabine—lung cancer	0.00135	0.00243	CcSEcCtD
Pasireotide—Fatigue—Erlotinib—lung cancer	0.00135	0.00242	CcSEcCtD
Pasireotide—Injection site reaction—Doxorubicin—lung cancer	0.00134	0.00241	CcSEcCtD
Pasireotide—Constipation—Erlotinib—lung cancer	0.00134	0.00241	CcSEcCtD
Pasireotide—Headache—Teniposide—lung cancer	0.00134	0.0024	CcSEcCtD
Pasireotide—Gastrointestinal pain—Vinblastine—lung cancer	0.00133	0.00239	CcSEcCtD
Pasireotide—Back pain—Irinotecan—lung cancer	0.00132	0.00238	CcSEcCtD
Pasireotide—Diabetes mellitus—Methotrexate—lung cancer	0.0013	0.00234	CcSEcCtD
Pasireotide—Gastrointestinal pain—Topotecan—lung cancer	0.00129	0.00232	CcSEcCtD
Pasireotide—Back pain—Gemcitabine—lung cancer	0.00129	0.00232	CcSEcCtD
Pasireotide—Abdominal pain—Vinblastine—lung cancer	0.00129	0.00231	CcSEcCtD
Pasireotide—Gastrointestinal pain—Erlotinib—lung cancer	0.00128	0.0023	CcSEcCtD
Pasireotide—Nausea—Teniposide—lung cancer	0.00127	0.00228	CcSEcCtD
Pasireotide—Hypotension—Vinorelbine—lung cancer	0.00126	0.00227	CcSEcCtD
Pasireotide—Anaemia—Irinotecan—lung cancer	0.00126	0.00227	CcSEcCtD
Pasireotide—Oedema peripheral—Paclitaxel—lung cancer	0.00126	0.00227	CcSEcCtD
Pasireotide—Alopecia—Cisplatin—lung cancer	0.00126	0.00226	CcSEcCtD
Pasireotide—Abdominal pain—Topotecan—lung cancer	0.00125	0.00225	CcSEcCtD
Pasireotide—Abdominal pain—Erlotinib—lung cancer	0.00124	0.00222	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.00123	0.00222	CcSEcCtD
Pasireotide—Anaemia—Gemcitabine—lung cancer	0.00123	0.00221	CcSEcCtD
Pasireotide—Vertigo—Irinotecan—lung cancer	0.00123	0.00221	CcSEcCtD
Pasireotide—Hypertension—Irinotecan—lung cancer	0.00118	0.00212	CcSEcCtD
Pasireotide—Decreased appetite—Vinorelbine—lung cancer	0.00118	0.00211	CcSEcCtD
Pasireotide—Asthenia—Vinblastine—lung cancer	0.00117	0.0021	CcSEcCtD
Pasireotide—Fatigue—Vinorelbine—lung cancer	0.00117	0.0021	CcSEcCtD
Pasireotide—Constipation—Vinorelbine—lung cancer	0.00116	0.00208	CcSEcCtD
Pasireotide—Alopecia—Etoposide—lung cancer	0.00115	0.00207	CcSEcCtD
Pasireotide—Hypertension—Gemcitabine—lung cancer	0.00115	0.00207	CcSEcCtD
Pasireotide—Anaemia—Cisplatin—lung cancer	0.00115	0.00206	CcSEcCtD
Pasireotide—Asthenia—Topotecan—lung cancer	0.00113	0.00204	CcSEcCtD
Pasireotide—Myalgia—Gemcitabine—lung cancer	0.00113	0.00204	CcSEcCtD
Pasireotide—Arthralgia—Gemcitabine—lung cancer	0.00113	0.00204	CcSEcCtD
Pasireotide—Alopecia—Paclitaxel—lung cancer	0.00113	0.00203	CcSEcCtD
Pasireotide—Diabetes mellitus—Doxorubicin—lung cancer	0.00113	0.00202	CcSEcCtD
Pasireotide—Asthenia—Erlotinib—lung cancer	0.00112	0.00202	CcSEcCtD
Pasireotide—Pruritus—Topotecan—lung cancer	0.00112	0.00201	CcSEcCtD
Pasireotide—Diarrhoea—Vinblastine—lung cancer	0.00111	0.002	CcSEcCtD
Pasireotide—Pruritus—Erlotinib—lung cancer	0.00111	0.00199	CcSEcCtD
Pasireotide—Gastrointestinal pain—Vinorelbine—lung cancer	0.00111	0.00199	CcSEcCtD
Pasireotide—Back pain—Etoposide—lung cancer	0.0011	0.00198	CcSEcCtD
Pasireotide—Diarrhoea—Topotecan—lung cancer	0.00108	0.00194	CcSEcCtD
Pasireotide—Back pain—Paclitaxel—lung cancer	0.00108	0.00194	CcSEcCtD
Pasireotide—Dizziness—Vinblastine—lung cancer	0.00108	0.00193	CcSEcCtD
Pasireotide—Diarrhoea—Erlotinib—lung cancer	0.00107	0.00192	CcSEcCtD
Pasireotide—Abdominal pain—Vinorelbine—lung cancer	0.00107	0.00192	CcSEcCtD
Pasireotide—Oedema peripheral—Docetaxel—lung cancer	0.00107	0.00192	CcSEcCtD
Pasireotide—Myalgia—Cisplatin—lung cancer	0.00106	0.0019	CcSEcCtD
Pasireotide—Anxiety—Cisplatin—lung cancer	0.00105	0.00189	CcSEcCtD
Pasireotide—Anaemia—Etoposide—lung cancer	0.00105	0.00189	CcSEcCtD
Pasireotide—Dizziness—Topotecan—lung cancer	0.00105	0.00188	CcSEcCtD
Pasireotide—Hypotension—Irinotecan—lung cancer	0.00104	0.00187	CcSEcCtD
Pasireotide—Vomiting—Vinblastine—lung cancer	0.00103	0.00186	CcSEcCtD
Pasireotide—Dizziness—Erlotinib—lung cancer	0.00103	0.00186	CcSEcCtD
Pasireotide—Anaemia—Paclitaxel—lung cancer	0.00103	0.00185	CcSEcCtD
Pasireotide—Vertigo—Etoposide—lung cancer	0.00102	0.00184	CcSEcCtD
Pasireotide—Headache—Vinblastine—lung cancer	0.00102	0.00183	CcSEcCtD
Pasireotide—Hypotension—Gemcitabine—lung cancer	0.00101	0.00183	CcSEcCtD
Pasireotide—Insomnia—Irinotecan—lung cancer	0.00101	0.00181	CcSEcCtD
Pasireotide—Vomiting—Topotecan—lung cancer	0.001	0.00181	CcSEcCtD
Pasireotide—Hypoglycaemia—Doxorubicin—lung cancer	0.001	0.0018	CcSEcCtD
Pasireotide—Vertigo—Paclitaxel—lung cancer	0.001	0.0018	CcSEcCtD
Pasireotide—Vomiting—Erlotinib—lung cancer	0.000994	0.00179	CcSEcCtD
Pasireotide—Headache—Topotecan—lung cancer	0.00099	0.00178	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.00099	0.00178	CcSEcCtD
Pasireotide—Insomnia—Gemcitabine—lung cancer	0.000982	0.00177	CcSEcCtD
Pasireotide—Hypertension—Etoposide—lung cancer	0.000981	0.00176	CcSEcCtD
Pasireotide—Headache—Erlotinib—lung cancer	0.00098	0.00176	CcSEcCtD
Pasireotide—Pain in extremity—Doxorubicin—lung cancer	0.000979	0.00176	CcSEcCtD
Pasireotide—Asthenia—Vinorelbine—lung cancer	0.00097	0.00174	CcSEcCtD
Pasireotide—Decreased appetite—Irinotecan—lung cancer	0.000969	0.00174	CcSEcCtD
Pasireotide—Nausea—Vinblastine—lung cancer	0.000966	0.00174	CcSEcCtD
Pasireotide—Hypertension—Paclitaxel—lung cancer	0.000962	0.00173	CcSEcCtD
Pasireotide—Fatigue—Irinotecan—lung cancer	0.000961	0.00173	CcSEcCtD
Pasireotide—Alopecia—Docetaxel—lung cancer	0.000959	0.00172	CcSEcCtD
Pasireotide—Pruritus—Vinorelbine—lung cancer	0.000956	0.00172	CcSEcCtD
Pasireotide—Constipation—Irinotecan—lung cancer	0.000953	0.00171	CcSEcCtD
Pasireotide—Arthralgia—Paclitaxel—lung cancer	0.000949	0.00171	CcSEcCtD
Pasireotide—Myalgia—Paclitaxel—lung cancer	0.000949	0.00171	CcSEcCtD
Pasireotide—Hypotension—Cisplatin—lung cancer	0.000946	0.0017	CcSEcCtD
Pasireotide—Anxiety—Paclitaxel—lung cancer	0.000945	0.0017	CcSEcCtD
Pasireotide—Decreased appetite—Gemcitabine—lung cancer	0.000944	0.0017	CcSEcCtD
Pasireotide—Nausea—Topotecan—lung cancer	0.000939	0.00169	CcSEcCtD
Pasireotide—Fatigue—Gemcitabine—lung cancer	0.000936	0.00168	CcSEcCtD
Pasireotide—Constipation—Gemcitabine—lung cancer	0.000929	0.00167	CcSEcCtD
Pasireotide—Nausea—Erlotinib—lung cancer	0.000929	0.00167	CcSEcCtD
Pasireotide—Diarrhoea—Vinorelbine—lung cancer	0.000925	0.00166	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000922	0.00166	CcSEcCtD
Pasireotide—Back pain—Docetaxel—lung cancer	0.000913	0.00164	CcSEcCtD
Pasireotide—Gastrointestinal pain—Irinotecan—lung cancer	0.000912	0.00164	CcSEcCtD
Pasireotide—Dry skin—Doxorubicin—lung cancer	0.000897	0.00161	CcSEcCtD
Pasireotide—Dizziness—Vinorelbine—lung cancer	0.000894	0.00161	CcSEcCtD
Pasireotide—Abdominal pain upper—Doxorubicin—lung cancer	0.000894	0.00161	CcSEcCtD
Pasireotide—Hypokalaemia—Doxorubicin—lung cancer	0.000891	0.0016	CcSEcCtD
Pasireotide—Abdominal pain—Irinotecan—lung cancer	0.000881	0.00159	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.000881	0.00159	CcSEcCtD
Pasireotide—Decreased appetite—Cisplatin—lung cancer	0.00088	0.00158	CcSEcCtD
Pasireotide—Nasopharyngitis—Doxorubicin—lung cancer	0.000875	0.00157	CcSEcCtD
Pasireotide—Anaemia—Docetaxel—lung cancer	0.000873	0.00157	CcSEcCtD
Pasireotide—Hypotension—Etoposide—lung cancer	0.000867	0.00156	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.000863	0.00155	CcSEcCtD
Pasireotide—Vomiting—Vinorelbine—lung cancer	0.00086	0.00155	CcSEcCtD
Pasireotide—Abdominal distension—Doxorubicin—lung cancer	0.000852	0.00153	CcSEcCtD
Pasireotide—Hypotension—Paclitaxel—lung cancer	0.00085	0.00153	CcSEcCtD
Pasireotide—Headache—Vinorelbine—lung cancer	0.000847	0.00152	CcSEcCtD
Pasireotide—Influenza—Doxorubicin—lung cancer	0.000846	0.00152	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000828	0.00149	CcSEcCtD
Pasireotide—Insomnia—Paclitaxel—lung cancer	0.000822	0.00148	CcSEcCtD
Pasireotide—Hypertension—Docetaxel—lung cancer	0.000815	0.00147	CcSEcCtD
Pasireotide—Decreased appetite—Etoposide—lung cancer	0.000806	0.00145	CcSEcCtD
Pasireotide—Arthralgia—Docetaxel—lung cancer	0.000804	0.00145	CcSEcCtD
Pasireotide—Myalgia—Docetaxel—lung cancer	0.000804	0.00145	CcSEcCtD
Pasireotide—Nausea—Vinorelbine—lung cancer	0.000803	0.00144	CcSEcCtD
Pasireotide—Asthenia—Irinotecan—lung cancer	0.0008	0.00144	CcSEcCtD
Pasireotide—Fatigue—Etoposide—lung cancer	0.0008	0.00144	CcSEcCtD
Pasireotide—Constipation—Etoposide—lung cancer	0.000793	0.00143	CcSEcCtD
Pasireotide—Decreased appetite—Paclitaxel—lung cancer	0.00079	0.00142	CcSEcCtD
Pasireotide—Fatigue—Paclitaxel—lung cancer	0.000784	0.00141	CcSEcCtD
Pasireotide—Asthenia—Gemcitabine—lung cancer	0.000779	0.0014	CcSEcCtD
Pasireotide—Constipation—Paclitaxel—lung cancer	0.000778	0.0014	CcSEcCtD
Pasireotide—Pruritus—Gemcitabine—lung cancer	0.000768	0.00138	CcSEcCtD
Pasireotide—Hyperglycaemia—Doxorubicin—lung cancer	0.000763	0.00137	CcSEcCtD
Pasireotide—Diarrhoea—Irinotecan—lung cancer	0.000763	0.00137	CcSEcCtD
Pasireotide—Gastrointestinal pain—Etoposide—lung cancer	0.000758	0.00136	CcSEcCtD
Pasireotide—Gastrointestinal pain—Paclitaxel—lung cancer	0.000744	0.00134	CcSEcCtD
Pasireotide—Diarrhoea—Gemcitabine—lung cancer	0.000743	0.00134	CcSEcCtD
Pasireotide—Dizziness—Irinotecan—lung cancer	0.000737	0.00133	CcSEcCtD
Pasireotide—Abdominal pain—Etoposide—lung cancer	0.000733	0.00132	CcSEcCtD
Pasireotide—Asthenia—Cisplatin—lung cancer	0.000726	0.00131	CcSEcCtD
Pasireotide—Hypotension—Docetaxel—lung cancer	0.00072	0.0013	CcSEcCtD
Pasireotide—Abdominal pain—Paclitaxel—lung cancer	0.000719	0.00129	CcSEcCtD
Pasireotide—Vomiting—Irinotecan—lung cancer	0.000709	0.00128	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000702	0.00126	CcSEcCtD
Pasireotide—Headache—Irinotecan—lung cancer	0.000698	0.00126	CcSEcCtD
Pasireotide—Insomnia—Docetaxel—lung cancer	0.000697	0.00125	CcSEcCtD
Pasireotide—Diarrhoea—Cisplatin—lung cancer	0.000693	0.00125	CcSEcCtD
Pasireotide—Alopecia—Methotrexate—lung cancer	0.000691	0.00124	CcSEcCtD
Pasireotide—Vomiting—Gemcitabine—lung cancer	0.000691	0.00124	CcSEcCtD
Pasireotide—Headache—Gemcitabine—lung cancer	0.00068	0.00122	CcSEcCtD
Pasireotide—Decreased appetite—Docetaxel—lung cancer	0.00067	0.00121	CcSEcCtD
Pasireotide—Oedema peripheral—Doxorubicin—lung cancer	0.000667	0.0012	CcSEcCtD
Pasireotide—Asthenia—Etoposide—lung cancer	0.000665	0.0012	CcSEcCtD
Pasireotide—Fatigue—Docetaxel—lung cancer	0.000665	0.0012	CcSEcCtD
Pasireotide—Nausea—Irinotecan—lung cancer	0.000662	0.00119	CcSEcCtD
Pasireotide—Constipation—Docetaxel—lung cancer	0.000659	0.00119	CcSEcCtD
Pasireotide—Back pain—Methotrexate—lung cancer	0.000658	0.00118	CcSEcCtD
Pasireotide—Pruritus—Etoposide—lung cancer	0.000656	0.00118	CcSEcCtD
Pasireotide—Asthenia—Paclitaxel—lung cancer	0.000652	0.00117	CcSEcCtD
Pasireotide—Nausea—Gemcitabine—lung cancer	0.000645	0.00116	CcSEcCtD
Pasireotide—Vomiting—Cisplatin—lung cancer	0.000644	0.00116	CcSEcCtD
Pasireotide—Pruritus—Paclitaxel—lung cancer	0.000643	0.00116	CcSEcCtD
Pasireotide—Diarrhoea—Etoposide—lung cancer	0.000635	0.00114	CcSEcCtD
Pasireotide—Gastrointestinal pain—Docetaxel—lung cancer	0.00063	0.00113	CcSEcCtD
Pasireotide—Anaemia—Methotrexate—lung cancer	0.000629	0.00113	CcSEcCtD
Pasireotide—Diarrhoea—Paclitaxel—lung cancer	0.000622	0.00112	CcSEcCtD
Pasireotide—Dizziness—Etoposide—lung cancer	0.000613	0.0011	CcSEcCtD
Pasireotide—Vertigo—Methotrexate—lung cancer	0.000612	0.0011	CcSEcCtD
Pasireotide—Abdominal pain—Docetaxel—lung cancer	0.000609	0.0011	CcSEcCtD
Pasireotide—Dizziness—Paclitaxel—lung cancer	0.000601	0.00108	CcSEcCtD
Pasireotide—Nausea—Cisplatin—lung cancer	0.000601	0.00108	CcSEcCtD
Pasireotide—Alopecia—Doxorubicin—lung cancer	0.000598	0.00108	CcSEcCtD
Pasireotide—Vomiting—Etoposide—lung cancer	0.00059	0.00106	CcSEcCtD
Pasireotide—Headache—Etoposide—lung cancer	0.000581	0.00105	CcSEcCtD
Pasireotide—Myalgia—Methotrexate—lung cancer	0.000579	0.00104	CcSEcCtD
Pasireotide—Arthralgia—Methotrexate—lung cancer	0.000579	0.00104	CcSEcCtD
Pasireotide—Vomiting—Paclitaxel—lung cancer	0.000578	0.00104	CcSEcCtD
Pasireotide—Back pain—Doxorubicin—lung cancer	0.00057	0.00103	CcSEcCtD
Pasireotide—Headache—Paclitaxel—lung cancer	0.00057	0.00102	CcSEcCtD
Pasireotide—Asthenia—Docetaxel—lung cancer	0.000553	0.000995	CcSEcCtD
Pasireotide—Nausea—Etoposide—lung cancer	0.000551	0.000991	CcSEcCtD
Pasireotide—Pruritus—Docetaxel—lung cancer	0.000545	0.000981	CcSEcCtD
Pasireotide—Anaemia—Doxorubicin—lung cancer	0.000545	0.00098	CcSEcCtD
Pasireotide—Nausea—Paclitaxel—lung cancer	0.00054	0.000972	CcSEcCtD
Pasireotide—Vertigo—Doxorubicin—lung cancer	0.00053	0.000952	CcSEcCtD
Pasireotide—Diarrhoea—Docetaxel—lung cancer	0.000527	0.000949	CcSEcCtD
Pasireotide—Hypotension—Methotrexate—lung cancer	0.000519	0.000934	CcSEcCtD
Pasireotide—Dizziness—Docetaxel—lung cancer	0.00051	0.000917	CcSEcCtD
Pasireotide—Hypertension—Doxorubicin—lung cancer	0.000509	0.000915	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000506	0.00091	CcSEcCtD
Pasireotide—Insomnia—Methotrexate—lung cancer	0.000502	0.000904	CcSEcCtD
Pasireotide—Arthralgia—Doxorubicin—lung cancer	0.000502	0.000903	CcSEcCtD
Pasireotide—Myalgia—Doxorubicin—lung cancer	0.000502	0.000903	CcSEcCtD
Pasireotide—Anxiety—Doxorubicin—lung cancer	0.0005	0.000899	CcSEcCtD
Pasireotide—Vomiting—Docetaxel—lung cancer	0.00049	0.000881	CcSEcCtD
Pasireotide—Decreased appetite—Methotrexate—lung cancer	0.000483	0.000869	CcSEcCtD
Pasireotide—Headache—Docetaxel—lung cancer	0.000483	0.000868	CcSEcCtD
Pasireotide—Fatigue—Methotrexate—lung cancer	0.000479	0.000861	CcSEcCtD
Pasireotide—Nausea—Docetaxel—lung cancer	0.000458	0.000823	CcSEcCtD
Pasireotide—Gastrointestinal pain—Methotrexate—lung cancer	0.000454	0.000817	CcSEcCtD
Pasireotide—Hypotension—Doxorubicin—lung cancer	0.000449	0.000808	CcSEcCtD
Pasireotide—Abdominal pain—Methotrexate—lung cancer	0.000439	0.00079	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000438	0.000788	CcSEcCtD
Pasireotide—Insomnia—Doxorubicin—lung cancer	0.000435	0.000783	CcSEcCtD
Pasireotide—Decreased appetite—Doxorubicin—lung cancer	0.000418	0.000752	CcSEcCtD
Pasireotide—Fatigue—Doxorubicin—lung cancer	0.000415	0.000746	CcSEcCtD
Pasireotide—Constipation—Doxorubicin—lung cancer	0.000411	0.00074	CcSEcCtD
Pasireotide—Asthenia—Methotrexate—lung cancer	0.000399	0.000717	CcSEcCtD
Pasireotide—Gastrointestinal pain—Doxorubicin—lung cancer	0.000393	0.000708	CcSEcCtD
Pasireotide—Pruritus—Methotrexate—lung cancer	0.000393	0.000707	CcSEcCtD
Pasireotide—Abdominal pain—Doxorubicin—lung cancer	0.00038	0.000684	CcSEcCtD
Pasireotide—Diarrhoea—Methotrexate—lung cancer	0.00038	0.000684	CcSEcCtD
Pasireotide—Dizziness—Methotrexate—lung cancer	0.000367	0.000661	CcSEcCtD
Pasireotide—Vomiting—Methotrexate—lung cancer	0.000353	0.000635	CcSEcCtD
Pasireotide—Headache—Methotrexate—lung cancer	0.000348	0.000626	CcSEcCtD
Pasireotide—Asthenia—Doxorubicin—lung cancer	0.000345	0.000621	CcSEcCtD
Pasireotide—Pruritus—Doxorubicin—lung cancer	0.00034	0.000612	CcSEcCtD
Pasireotide—Nausea—Methotrexate—lung cancer	0.00033	0.000594	CcSEcCtD
Pasireotide—Diarrhoea—Doxorubicin—lung cancer	0.000329	0.000592	CcSEcCtD
Pasireotide—Dizziness—Doxorubicin—lung cancer	0.000318	0.000572	CcSEcCtD
Pasireotide—Vomiting—Doxorubicin—lung cancer	0.000306	0.00055	CcSEcCtD
Pasireotide—Headache—Doxorubicin—lung cancer	0.000301	0.000542	CcSEcCtD
Pasireotide—Nausea—Doxorubicin—lung cancer	0.000286	0.000514	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—HES1—lung cancer	0.000245	0.000552	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—PIK3CB—lung cancer	0.000245	0.000551	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—PIK3CD—lung cancer	0.000243	0.000546	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—RAF1—lung cancer	0.00024	0.000541	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—MAP2K1—lung cancer	0.00024	0.000541	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PIK3CD—lung cancer	0.000239	0.000538	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—POMC—lung cancer	0.000239	0.000537	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—IL2—lung cancer	0.000237	0.000534	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—CXCL8—lung cancer	0.000235	0.00053	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—PIK3CB—lung cancer	0.000235	0.000528	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—STK11—lung cancer	0.000234	0.000528	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—ERBB3—lung cancer	0.000234	0.000526	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL6R—lung cancer	0.000233	0.000524	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—AVP—lung cancer	0.00023	0.000517	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—PIK3CB—lung cancer	0.000229	0.000516	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—FOXO3—lung cancer	0.000226	0.00051	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—CXCL8—lung cancer	0.000225	0.000508	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—IL2—lung cancer	0.000225	0.000506	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—ERBB3—lung cancer	0.000224	0.000504	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TERT—lung cancer	0.000224	0.000504	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—MAP2K1—lung cancer	0.000222	0.000499	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IGF1R—lung cancer	0.000221	0.000498	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PIK3CD—lung cancer	0.00022	0.000496	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—CXCL8—lung cancer	0.00022	0.000496	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—FGFR1—lung cancer	0.000217	0.00049	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HES1—lung cancer	0.000217	0.000489	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—IL2—lung cancer	0.000215	0.000485	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TERT—lung cancer	0.000215	0.000483	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—HIF1A—lung cancer	0.000214	0.000482	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—RAF1—lung cancer	0.000213	0.00048	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—AVP—lung cancer	0.000212	0.000478	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—PIK3CB—lung cancer	0.000211	0.000476	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—IL2—lung cancer	0.00021	0.000474	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—FGFR1—lung cancer	0.000208	0.000469	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PIK3CB—lung cancer	0.000208	0.000469	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—APOA1—lung cancer	0.000207	0.000465	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—HIF1A—lung cancer	0.000205	0.000462	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—KDR—lung cancer	0.000205	0.000461	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IGF1R—lung cancer	0.000204	0.00046	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—CXCL8—lung cancer	0.000203	0.000458	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HES1—lung cancer	0.000201	0.000452	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—CXCL8—lung cancer	0.0002	0.00045	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—ERBB3—lung cancer	0.000199	0.000447	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—APOA1—lung cancer	0.000198	0.000446	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—RAF1—lung cancer	0.000197	0.000443	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—KDR—lung cancer	0.000196	0.000442	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—IL2—lung cancer	0.000194	0.000437	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PIK3CB—lung cancer	0.000192	0.000432	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—IL2—lung cancer	0.000191	0.00043	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TERT—lung cancer	0.00019	0.000429	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—APC—lung cancer	0.000189	0.000425	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CG—lung cancer	0.000189	0.000425	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—KIT—lung cancer	0.000189	0.000425	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—NRAS—lung cancer	0.000189	0.000425	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—EGF—lung cancer	0.000186	0.00042	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—FGFR1—lung cancer	0.000185	0.000416	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CXCL8—lung cancer	0.000185	0.000416	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—ERBB3—lung cancer	0.000183	0.000413	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HIF1A—lung cancer	0.000182	0.00041	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—APC—lung cancer	0.000181	0.000407	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—KIT—lung cancer	0.000181	0.000407	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CG—lung cancer	0.000181	0.000407	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—NRAS—lung cancer	0.000181	0.000407	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—MAPK3—lung cancer	0.000181	0.000407	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—POMC—lung cancer	0.00018	0.000404	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—EGF—lung cancer	0.000179	0.000403	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—BRAF—lung cancer	0.000177	0.000399	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL2—lung cancer	0.000176	0.000397	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—APOA1—lung cancer	0.000176	0.000396	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TERT—lung cancer	0.000176	0.000396	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL6R—lung cancer	0.000175	0.000395	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CREBBP—lung cancer	0.000175	0.000394	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—KDR—lung cancer	0.000174	0.000392	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—MAPK3—lung cancer	0.000173	0.00039	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—POMC—lung cancer	0.000172	0.000388	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—EGFR—lung cancer	0.000172	0.000387	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—FGFR1—lung cancer	0.000171	0.000384	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—BRAF—lung cancer	0.00017	0.000383	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HIF1A—lung cancer	0.000168	0.000378	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL6R—lung cancer	0.000168	0.000378	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CREBBP—lung cancer	0.000168	0.000378	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MAP2K1—lung cancer	0.000167	0.000376	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CD—lung cancer	0.000166	0.000373	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—EGFR—lung cancer	0.000165	0.000371	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—PIK3CA—lung cancer	0.000164	0.00037	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—KRAS—lung cancer	0.000162	0.000366	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—APOA1—lung cancer	0.000162	0.000365	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—KDR—lung cancer	0.000161	0.000362	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—APC—lung cancer	0.00016	0.000361	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CG—lung cancer	0.00016	0.000361	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—KIT—lung cancer	0.00016	0.000361	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—NRAS—lung cancer	0.00016	0.000361	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MAP2K1—lung cancer	0.00016	0.00036	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CD—lung cancer	0.000159	0.000358	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—EGF—lung cancer	0.000159	0.000357	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—PIK3CA—lung cancer	0.000157	0.000355	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—KRAS—lung cancer	0.000156	0.000351	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—MAPK3—lung cancer	0.000154	0.000346	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—POMC—lung cancer	0.000153	0.000344	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—BRAF—lung cancer	0.000151	0.00034	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—PIK3CA—lung cancer	0.000149	0.000336	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL6R—lung cancer	0.000149	0.000335	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CREBBP—lung cancer	0.000149	0.000335	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MDM2—lung cancer	0.000149	0.000335	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—RAF1—lung cancer	0.000148	0.000333	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—APC—lung cancer	0.000148	0.000333	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CG—lung cancer	0.000148	0.000333	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—KIT—lung cancer	0.000148	0.000333	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—NRAS—lung cancer	0.000148	0.000333	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—ERBB2—lung cancer	0.000146	0.00033	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—EGF—lung cancer	0.000146	0.00033	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—EGFR—lung cancer	0.000146	0.000329	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MTOR—lung cancer	0.000145	0.000326	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CB—lung cancer	0.000145	0.000326	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—PIK3CA—lung cancer	0.000143	0.000322	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MDM2—lung cancer	0.000142	0.000321	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—RAF1—lung cancer	0.000142	0.00032	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MAP2K1—lung cancer	0.000142	0.00032	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—MAPK3—lung cancer	0.000142	0.000319	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CD—lung cancer	0.000141	0.000318	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—POMC—lung cancer	0.000141	0.000317	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—ERBB2—lung cancer	0.00014	0.000316	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—PIK3CA—lung cancer	0.00014	0.000315	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—BRAF—lung cancer	0.000139	0.000313	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CXCL8—lung cancer	0.000139	0.000313	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MTOR—lung cancer	0.000139	0.000312	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CB—lung cancer	0.000139	0.000312	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—KRAS—lung cancer	0.000138	0.000311	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—HRAS—lung cancer	0.000138	0.000311	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL6R—lung cancer	0.000137	0.00031	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CREBBP—lung cancer	0.000137	0.000309	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—EGFR—lung cancer	0.000135	0.000304	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—AKT1—lung cancer	0.000134	0.000302	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CXCL8—lung cancer	0.000133	0.0003	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CASP3—lung cancer	0.000133	0.000299	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL2—lung cancer	0.000133	0.000299	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—HRAS—lung cancer	0.000132	0.000298	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—IL6—lung cancer	0.000132	0.000297	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MAP2K1—lung cancer	0.000131	0.000295	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CD—lung cancer	0.00013	0.000293	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CCND1—lung cancer	0.000129	0.000291	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—JUN—lung cancer	0.000129	0.000291	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—PIK3CA—lung cancer	0.000129	0.00029	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—AKT1—lung cancer	0.000129	0.00029	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CASP3—lung cancer	0.000127	0.000287	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—KRAS—lung cancer	0.000127	0.000287	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL2—lung cancer	0.000127	0.000287	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PIK3CA—lung cancer	0.000127	0.000286	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—IL6—lung cancer	0.000127	0.000285	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MDM2—lung cancer	0.000126	0.000285	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—RAF1—lung cancer	0.000126	0.000284	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MMP9—lung cancer	0.000126	0.000283	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CDKN1A—lung cancer	0.000125	0.000282	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PTEN—lung cancer	0.000125	0.000281	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—ERBB2—lung cancer	0.000125	0.000281	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCND1—lung cancer	0.000124	0.000279	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—JUN—lung cancer	0.000124	0.000279	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CB—lung cancer	0.000123	0.000277	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MTOR—lung cancer	0.000123	0.000277	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—AKT1—lung cancer	0.000122	0.000274	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MMP9—lung cancer	0.00012	0.000271	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CDKN1A—lung cancer	0.00012	0.00027	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PTEN—lung cancer	0.00012	0.00027	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—EP300—lung cancer	0.000119	0.000268	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CXCL8—lung cancer	0.000118	0.000266	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—HRAS—lung cancer	0.000117	0.000264	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PIK3CA—lung cancer	0.000117	0.000264	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—AKT1—lung cancer	0.000117	0.000263	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MDM2—lung cancer	0.000117	0.000263	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—RAF1—lung cancer	0.000116	0.000262	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—SRC—lung cancer	0.000116	0.000261	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—ERBB2—lung cancer	0.000115	0.000259	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—EP300—lung cancer	0.000114	0.000257	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—AKT1—lung cancer	0.000114	0.000257	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MTOR—lung cancer	0.000113	0.000255	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CB—lung cancer	0.000113	0.000255	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CASP3—lung cancer	0.000113	0.000255	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL2—lung cancer	0.000113	0.000254	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—VEGFA—lung cancer	0.000113	0.000254	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—IL6—lung cancer	0.000112	0.000253	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—STAT3—lung cancer	0.000112	0.000252	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NRAS—lung cancer	0.000111	0.000251	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—SRC—lung cancer	0.000111	0.00025	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCND1—lung cancer	0.00011	0.000248	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—JUN—lung cancer	0.00011	0.000247	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CXCL8—lung cancer	0.000109	0.000245	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—HRAS—lung cancer	0.000108	0.000244	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—VEGFA—lung cancer	0.000108	0.000244	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—STAT3—lung cancer	0.000107	0.000241	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NRAS—lung cancer	0.000107	0.000241	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MMP9—lung cancer	0.000107	0.000241	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MAPK3—lung cancer	0.000107	0.00024	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CDKN1A—lung cancer	0.000106	0.00024	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PTEN—lung cancer	0.000106	0.000239	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—AKT1—lung cancer	0.000105	0.000237	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CASP3—lung cancer	0.000104	0.000235	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL2—lung cancer	0.000104	0.000235	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MYC—lung cancer	0.000104	0.000234	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL6—lung cancer	0.000104	0.000233	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—AKT1—lung cancer	0.000104	0.000233	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MAPK3—lung cancer	0.000102	0.00023	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCND1—lung cancer	0.000102	0.000229	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—EGFR—lung cancer	0.000102	0.000229	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—JUN—lung cancer	0.000101	0.000228	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—EP300—lung cancer	0.000101	0.000228	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MYC—lung cancer	9.95e-05	0.000224	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MMP9—lung cancer	9.86e-05	0.000222	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SRC—lung cancer	9.85e-05	0.000222	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CDKN1A—lung cancer	9.82e-05	0.000221	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PTEN—lung cancer	9.8e-05	0.000221	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—EGFR—lung cancer	9.73e-05	0.000219	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—VEGFA—lung cancer	9.59e-05	0.000216	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—KRAS—lung cancer	9.59e-05	0.000216	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—AKT1—lung cancer	9.56e-05	0.000215	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—STAT3—lung cancer	9.5e-05	0.000214	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NRAS—lung cancer	9.48e-05	0.000213	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—EP300—lung cancer	9.35e-05	0.000211	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—KRAS—lung cancer	9.2e-05	0.000207	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SRC—lung cancer	9.09e-05	0.000205	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MAPK3—lung cancer	9.08e-05	0.000204	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—VEGFA—lung cancer	8.85e-05	0.000199	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MYC—lung cancer	8.83e-05	0.000199	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CA—lung cancer	8.81e-05	0.000198	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—STAT3—lung cancer	8.77e-05	0.000197	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NRAS—lung cancer	8.75e-05	0.000197	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—EGFR—lung cancer	8.63e-05	0.000194	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TP53—lung cancer	8.53e-05	0.000192	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CA—lung cancer	8.45e-05	0.00019	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MAPK3—lung cancer	8.38e-05	0.000189	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TP53—lung cancer	8.17e-05	0.000184	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—KRAS—lung cancer	8.16e-05	0.000184	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—HRAS—lung cancer	8.15e-05	0.000184	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MYC—lung cancer	8.15e-05	0.000183	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—EGFR—lung cancer	7.97e-05	0.000179	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—HRAS—lung cancer	7.82e-05	0.000176	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL6—lung cancer	7.8e-05	0.000176	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—KRAS—lung cancer	7.53e-05	0.00017	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CA—lung cancer	7.49e-05	0.000169	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL6—lung cancer	7.48e-05	0.000168	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TP53—lung cancer	7.25e-05	0.000163	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—AKT1—lung cancer	7.2e-05	0.000162	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HRAS—lung cancer	6.93e-05	0.000156	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CA—lung cancer	6.92e-05	0.000156	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—AKT1—lung cancer	6.9e-05	0.000155	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TP53—lung cancer	6.69e-05	0.000151	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL6—lung cancer	6.64e-05	0.000149	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HRAS—lung cancer	6.4e-05	0.000144	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL6—lung cancer	6.12e-05	0.000138	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—AKT1—lung cancer	6.12e-05	0.000138	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—AKT1—lung cancer	5.65e-05	0.000127	CbGpPWpGaD
